Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
S-Adenosylmethionine decarboxylase 1 (AMD1) is a key enzyme in the polyamine biosynthetic pathway, catalyzing the decarboxylation of S-adenosylmethionine (SAM) to produce S-adenosylmethioninamine (decarboxylated SAM). This product is essential for the synthesis of spermidine and spermine, which are critical for cell growth, proliferation, and DNA/RNA/protein synthesis. AMD1 is tightly regulated and plays a crucial role in diseases such as cancer and pulmonary hypertension, making it a potential therapeutic target.
Inhibition of S-adenosylmethionine decarboxylation, leading to decreased polyamine synthesis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on S-Adenosylmethionine Decarboxylase 1 (AMD1).